Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MOLECULAR TEMPLATES, INC.

(MTEM)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/26 12:18:12 pm
5.57 USD   -0.18%
10/22BB BIOTECH AG : BB Biotech: i ricavi -2-
DJ
10/22PRESS RELEASE : BB Biotech: Gains realized -2-
DJ
10/18MOLECULAR TEMPLATES : Vertex Terminates Collaboration
DJ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2021 10/21/2021 10/22/2021 10/25/2021 10/26/2021 Date
6.02(c) 6.08(c) 5.81(c) 5.58(c) 5.55 Last
139 128 83 538 181 666 157 893 52 981 Volume
-0.33% +1.00% -4.44% -3.96% -0.54% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 48,7 M - -
Net income 2021 -79,5 M - -
Net cash position 2021 56,1 M - -
P/E ratio 2021 -3,90x
Yield 2021 -
Sales 2022 39,0 M - -
Net income 2022 -113 M - -
Net cash position 2022 153 M - -
P/E ratio 2022 -3,22x
Yield 2022 -
Capitalization 313 M 313 M -
EV / Sales 2021 5,28x
EV / Sales 2022 4,12x
Nbr of Employees 254
Free-Float 72,5%
More Financials
Company
Molecular Templates, Inc. is a clinical stage biopharmaceutical company that is focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer and other serious diseases. The Company utilizes its biologic drug platform to design and generate engineered toxin bodies (ETBs). ETBs use a genetically engineered version of the Shiga-like Toxin A subunit (SLTA), a ribosome... 
More about the company
Ratings of Molecular Templates, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about MOLECULAR TEMPLATES, INC.
10/22BB BIOTECH AG : BB Biotech: i ricavi -2-
DJ
10/22PRESS RELEASE : BB Biotech: Gains realized -2-
DJ
10/18MOLECULAR TEMPLATES : Vertex Terminates Collaboration
DJ
10/18MOLECULAR TEMPLATES : Termination of a Material Definitive Agreement - Form 8-K
PU
10/18MOLECULAR TEMPLATES, INC. : Termination of a Material Definitive Agreement (form 8-K)
AQ
09/24MOLECULAR TEMPLATES : Shares Rise Amid Higher Trading Volume
MT
09/20MOLECULAR TEMPLATES : to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTec..
AQ
08/13MOLECULAR TEMPLATES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
08/12MOLECULAR TEMPLATES : Reports Second Quarter 2021 Financial Results (Form 8-K)
PU
08/12MOLECULAR TEMPLATES, INC. : Results of Operations and Financial Condition, Financial State..
AQ
08/12Molecular Templates, Inc. Reports Second Quarter 2021 Financial Results
GL
08/12MOLECULAR TEMPLATES : Earnings Flash (MTEM) MOLECULAR TEMPLATES Reports Q2 Revenue $15.1M
MT
07/30MOLECULAR TEMPLATES : UBS Adjusts PT on Molecular Templates to $8 From $13 on MT-3724 Disc..
MT
07/29MOLECULAR TEMPLATES : Insider purchase at Molecular Templates (MTEM) prolongs buy activity..
MT
07/28INSIDER TRENDS : Insider Purchase of Molecular Templates Stock Extends 90-Day Positive Tre..
MT
More news
News in other languages on MOLECULAR TEMPLATES, INC.
10/22BB BIOTECH : Gewinnrealisierungen -2-
09/24Les actions de Molecular Templates augmentent dans un volume de transactions plus élevé
07/23DGAP-NEWS : Biotechbranche mit solidem 2. Quartal -2-
07/23DGAP-NEWS : Biotechbranche mit solidem 2. Quartal - BB Biotech erhöht Allokation in aussic..
04/23DGAP-NEWS : BB BIOTECH AG: Erfolgreiche -2-
More news
Analyst Recommendations on MOLECULAR TEMPLATES, INC.
More recommendations
Chart MOLECULAR TEMPLATES, INC.
Duration : Period :
Molecular Templates, Inc. Technical Analysis Chart | MTEM | US6085501095 | MarketScreener
Technical analysis trends MOLECULAR TEMPLATES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 5,58 $
Average target price 13,43 $
Spread / Average Target 141%
EPS Revisions
Managers and Directors
Eric E. Poma CEO, Director & Chief Scientific Officer
Jason S. Kim President & Chief Operating Officer
Sean McLennan CFO, CAO, Senior VP-Finance & Controller
Harold E. Selick Chairman
Roger J. Waltzman Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
MOLECULAR TEMPLATES, INC.-38.13%313
GILEAD SCIENCES, INC.16.15%84 845
BIONTECH SE261.78%71 229
WUXI APPTEC CO., LTD.24.08%64 399
REGENERON PHARMACEUTICALS19.27%59 906
VERTEX PHARMACEUTICALS-21.73%47 992